Interested in investing in stocks? Looking for tips on how to find the best stocks to buy and watch? Join IBD every 2 weeks ...

Enterprise Pdts Partners shows rising price performance, earning an upgrade to its IBD Relative Strength Rating ...

IBD has performed objective research on decades' worth of IPO stocks, not simply on growth stocks in general. The innovator ...

Deckers is the IBD Stock Of The Day as it sprints past a buy point to a new high amid robust earnings and a positive analyst ...

The top-performing stocks in the index include Vistra (VST), Nvidia (NVDA), and Palantir (PLTR). On the other end, Walgreens Boots Alliance (WBA), Moderna (MRNA), and Dollar Tree (DLTR ...

Non-cap weighted indexes try to choose stocks that have a better chance of risk-return performance ... Because the fund has amassed over $331.38 million, this makes it one of the average sized ETFs in ...

WTX-921 is engineered using the PREDATOR® technology to deliver IL-10, a cytokine, selectively to inflamed tissues, such as the colon in IBD. The company's approach involves novel protease ...

Palisade Bio's progress with PALI-2108 is based on a press release statement and represents a step towards addressing the unmet needs in IBD treatment. In other recent news, Palisade Bio ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Clinical remission of IBD (defined as symptoms are under control) is not the only goal of treatment. The long-term goals of treatment include: Symptoms (such as bloody stool, bowel urgency, pain and ...